Emil Kuriakose's Net Worth

$5.69 Thousand

Estimate Recalculated Sep 17, 2024 11:50PM EST

Who is Emil Kuriakose

Emil Kuriakose does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Calithera Biosciences, Inc., and Terns Pharmaceuticals, Inc..

SEC CIK

Emil Kuriakose's CIK is 0001892413

Past Insider Trading and Trends

2021 was Emil Kuriakose's most active year for acquiring shares with 1 total transactions. Emil Kuriakose's most active month to acquire stocks was the month of December. 2022 was Emil Kuriakose's most active year for disposing of shares, totalling 2 transactions. Emil Kuriakose's most active month to dispose stocks was the month of December. 2022 saw Emil Kuriakose paying a total of $0.00 for 215,000 shares, this is the most they've acquired in one year. In 2021 Emil Kuriakose cashed out on 3,077 shares for a total of $2,676.99, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Calithera Biosciences, Inc.

CHIEF MEDICAL OFFICER
Updated Jan 25, 2023
Form 4
-2.18%
-79.00
$0.45
-$35.24
Jan 25, 2023
3.54K
Tax
Jan 23
Form 4
215.00K
Jan 27, 2022
215.00K
Grant
Jan 25
Form 4
-0.98%
-666.00
$0.49
-$327.34
Jan 25, 2022
67.37K
Tax
Jan 21
Form 4
-5.36%
-3.85K
$0.66
-$2.55K
Jan 06, 2022
68.04K
Tax
Jan 04
Form 4
14.76%
8.92K
$0.87
-$2.68K
Nov 09, 2021
69.39K
Grant
Nov 05 - Nov 08
Form 3
Nov 09, 2021
60.47K
Showing 6 results

Terns Pharmaceuticals, Inc.

Chief Medical Officer
Updated Mar 19, 2024
Form 3
Mar 19, 2024
58.75K
Showing 1 results